Literature DB >> 15870600

Sequential office pressure measurements in the management of glaucoma.

Nanny Collaer1, Thierry Zeyen, Joseph Caprioli.   

Abstract

PURPOSE: To evaluate the usefulness of day-long sequential office measurements of intraocular pressure (IOP) to make therapeutic decisions in patients with progressive glaucomatous damage despite apparently 'controlled' IOP.
METHODS: We reviewed the records of 93 consecutive glaucoma patients (185 eyes) who underwent sequential office IOP measurements (every hour from 7 AM to 5 PM on a single day). These included 53 patients with normal-tension glaucoma (NTG), 12 glaucoma suspects (GS), and 28 patients with primary open-angle glaucoma (POAG) whose visual field deteriorated despite apparently 'controlled' IOP. Only one eye per patient was included in the study.
RESULTS: The pattern of the day-long IOP curve was similar in the 3 groups of patients. IOPs were highest in the early morning hours in all groups. The mean +/- SD of the IOP range was 5 +/- 2 mm Hg. An IOP > 21 mm Hg was found in 3 eyes (3%), whereas a range of IOPs > 5 mm Hg was detected in 33 eyes (35%). In the NTG group, there was a significant correlation between visual field deterioration and the peak and range of IOP (P = 0.0002 and P = 0.05, respectively).
CONCLUSIONS: Day-long sequential office IOP measurements are useful in selected patients who demonstrate progressive glaucomatous damage. Early morning measurements are most frequently highest. The range of IOP may be as important, or more important than, the peak IOP level.

Entities:  

Mesh:

Year:  2005        PMID: 15870600     DOI: 10.1097/01.ijg.0000159125.34241.79

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  13 in total

1.  Diurnal intraocular pressure fluctuation and its risk factors in angle-closure and open-angle glaucoma.

Authors:  S Srinivasan; N S Choudhari; M Baskaran; R J George; B Shantha; L Vijaya
Journal:  Eye (Lond)       Date:  2015-11-13       Impact factor: 3.775

2.  Variation in Intraocular Pressure and the Risk of Developing Open-Angle Glaucoma: The Los Angeles Latino Eye Study.

Authors:  Xuejuan Jiang; Mina Torres; Rohit Varma
Journal:  Am J Ophthalmol       Date:  2018-01-31       Impact factor: 5.258

3.  Diurnal tension curves for assessing the development or progression of glaucoma: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2011-06-01

Review 4.  Is 24-hour intraocular pressure monitoring necessary in glaucoma?

Authors:  Kaweh Mansouri; Robert N Weinreb; Felipe A Medeiros
Journal:  Semin Ophthalmol       Date:  2013-05       Impact factor: 1.975

Review 5.  An overview of home tonometry and telemetry for intraocular pressure monitoring in humans.

Authors:  Edward Yung; Valerie Trubnik; L Jay Katz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-29       Impact factor: 3.117

6.  Selective laser trabeculoplasty reduces mean IOP and IOP variation in normal tension glaucoma patients.

Authors:  Mohammed K El Mallah; Molly M Walsh; Sandra S Stinnett; Sanjay G Asrani
Journal:  Clin Ophthalmol       Date:  2010-08-09

7.  Continuous 24-hour ocular dimensional profile recording in medically treated normal-tension glaucoma.

Authors:  Jacky Wy Lee; Lin Fu; Jennifer Wh Shum; Jonathan Ch Chan; Jimmy Sm Lai
Journal:  Clin Ophthalmol       Date:  2015-01-29

Review 8.  24-h Efficacy of Glaucoma Treatment Options.

Authors:  Anastasios G P Konstas; Luciano Quaranta; Banu Bozkurt; Andreas Katsanos; Julian Garcia-Feijoo; Luca Rossetti; Tarek Shaarawy; Norbert Pfeiffer; Stefano Miglior
Journal:  Adv Ther       Date:  2016-02-24       Impact factor: 3.845

9.  Twenty-four-hour intraocular pressure related changes following adjuvant selective laser trabeculoplasty for normal tension glaucoma.

Authors:  Jacky W Y Lee; Lin Fu; Jonathan C H Chan; Jimmy S M Lai
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

Review 10.  Noninvasive intraocular pressure monitoring: current insights.

Authors:  Stefan De Smedt
Journal:  Clin Ophthalmol       Date:  2015-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.